0001671687-17-000001.txt : 20170118 0001671687-17-000001.hdr.sgml : 20170118 20170118165603 ACCESSION NUMBER: 0001671687-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170118 DATE AS OF CHANGE: 20170118 EFFECTIVENESS DATE: 20170118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vividion Therapeutics, Inc. CENTRAL INDEX KEY: 0001671687 IRS NUMBER: 464373293 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-278715 FILM NUMBER: 17533961 BUSINESS ADDRESS: STREET 1: 230 NASSAU STREET CITY: PRINCETON STATE: NJ ZIP: 08542 BUSINESS PHONE: 6099246452 MAIL ADDRESS: STREET 1: 230 NASSAU STREET CITY: PRINCETON STATE: NJ ZIP: 08542 D 1 primary_doc.xml X0707 D LIVE 0001671687 Vividion Therapeutics, Inc. 230 NASSAU STREET PRINCETON NJ NEW JERSEY 08542 6099246452 DELAWARE Cardinal LS, Inc. None Corporation true 2013 John K. Clarke c/o Cardinal Partners, 230 Nassau Street Princeton NJ NEW JERSEY 08542 Executive Officer Director John Park c/o Cardinal Partners, 230 Nassau Street Princeton NJ NEW JERSEY 08542 Executive Officer Benjamin Cravatt c/o Cardinal Partners, 230 Nassau Street Princeton NJ NEW JERSEY 08542 Director Biotechnology Decline to Disclose 06b false 2017-01-03 true true false 0 50500000 20200000 30300000 false 8 0 0 0 false Vividion Therapeutics, Inc. /s/John K. Clarke John K. Clarke President 2017-01-17